Cleveland Clinic revealed their Top 10 Medical Innovations for 2020 at the 2019 Medical Innovation Summit this week. The focus for the 17th annual summit was “Caring for Every Life Through Innovation.”
According to their website:
The annual Top 10 Medical Innovations was developed to share what our clinical leaders are saying to each other and what innovations they feel will help shape healthcare over the next 12 months and beyond.
They have multiple criteria that medical innovations have to meet before they are considered, including: (a) significant clinical impact; (b) significant patient benefit; (c) high user-related functionality that improves healthcare delivery; (d) high probability of commercial success; (e) available on the market in the next year; (f) must have significant human interest in its application or benefits; and (g) must have the ability to visualize human impact.
This year the Top 10 list includes:
- Dual-Acting Osteoporosis Drug
- Expanded Use of Minimally Invasive Mitral Valve Surgery
- Inaugural Treatment for Transthyretin Amyloid Cardiomyopathy
- Therapy for Peanut Allergies
- Closed-Loop Spinal Cord Stimulation
- Biologics in Orthopedic Repair
- Antibiotic Envelope for Cardiac Implantable Device Infection Prevention
- Bempedoic Acid for Cholesterol-Lowering in Statin Intolerant Patients
- PARP Inhibitors for Maintenance Therapy in Ovarian Cancer
- Drugs for Heart Failure with Preserved Ejection Fraction